glp-1 drugs stocks Best Weight Loss Drug to Buy in 2026 Market Overview: GLP-1 Agonists and

Figure 1 Statements Author contributions JC, AM, YW, CL, HQ, XM, HY, and LD searched the data, JC, XR, and JZ wrote the main manuscript text

Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B

S., Bueno, A

Side Effects and Safety: Short-Term Considerations Most people will encounter gastrointestinal effects early in therapy, especially during dose escalation

A study of liraglutide identified 0.188 cases per 100 person-years (PY) versus 0.154 in patients taking MET (an SU) or pioglitazone (a TZD)

Preclinical studies indicate that GLP-1 RAs can attenuate atherosclerosis by reducing vascular inflammation, lowering oxidative stress, and inhibiting the proliferation and activation of vascular smooth muscle cells [51, 52]